← Back to browse
HR 27 Passed a chamber

Places fentanyl-related substances in Schedule I of the Controlled Substances Act by defining them according to their chemical structure, and creates faster registration routes for researchers studying Schedule I drugs.

Official title: HALT Fentanyl Act

Next stop Senate: awaiting action
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced 03-JAN-2025
Referred 03-JAN-2025
On the calendar 04-FEB-2025
Passed 06-FEB-2025
Senate
Received 10-FEB-2025
Key points
  • Defines fentanyl-related substances by chemical structure and places any substance that fits the definition in Schedule I, whether or not it appears on a list.
  • Lets the Attorney General publish a list of covered substances in the Federal Register, but an unlisted substance that meets the definition stays controlled.
  • Allows researchers to start Schedule I work after a 30-day notice to the Attorney General when the research is federally funded or tied to an approved drug study, and requires DOJ's Inspector General to study fentanyl research within one year of enactment.
  • Adds fentanyl-related substances to the federal trafficking penalty provisions and requires the Attorney General to issue implementing rules within 6 months.
AI-generated from the Referred in Senate text of 10-FEB-2025 · verify · report an error
Official CRS summary

Covers an older version. The newest CRS summary describes the bill as of "Introduced in House" (03-JAN-2025); the text has changed since (Engrossed in House, 06-FEB-2025).

CRS is the Library of Congress's nonpartisan research office. Read it on congress.gov
Committee referrals (3) Policy area

Crime and Law Enforcement

Sponsor H. Morgan Griffith (R-VA) Cosponsors · 61
■ 58 R■ 2 D■ 1 I
1 Independent